Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -549.21%-505.61K | -366.82K | -73.65%-850.95K | -433.10%-739.84K | 81.47%-33.23K | -77.88K | 0 | 16.92%-490.04K | -138.78K | -179.36K |
| Net income from continuing operations | -19.85%-551.8K | -2,136.68%-175.24K | -488.06%-3.7M | -1,194.01%-2.93M | -89.82%-306.15K | ---460.42K | ---7.84K | 21.93%-629.76K | ---226.35K | ---161.28K |
| Other non cashItems | ---- | ---- | 391.95%1.62M | 600.31%1.2M | --48.02K | ---- | ---- | 85.33%329.08K | --171.04K | --0 |
| Change In working capital | 389.86%46.19K | -2,545.07%-191.57K | 751.42%1.23M | 1,287.74%991.36K | 1,343.96%224.9K | --9.43K | --7.84K | -581.89%-189.36K | ---83.47K | ---18.08K |
| -Change in receivables | ---3.52K | ---11.25K | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | --2.72K | --10.12K | ---18.44K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | 13.63%46.98K | -2,530.64%-190.44K | 840.75%1.37M | 1,392.62%1.07M | 1,641.57%253.53K | --41.35K | --7.84K | -151,568.85%-184.79K | ---82.48K | ---16.45K |
| -Change in other current assets | ---- | ---- | -2,459.27%-116.88K | -5,607.70%-56.34K | -1,653.21%-28.63K | ---- | ---- | 4.07%-4.57K | ---987 | ---1.63K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -549.21%-505.61K | ---366.82K | -73.65%-850.95K | -433.10%-739.84K | 81.47%-33.23K | ---77.88K | --0 | 16.92%-490.04K | ---138.78K | ---179.36K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -75.56K | 39.59%-48.33K | -48.33K | 0 | 0 | 0 | -60.00%-80K | 0 | 0 |
| Net PPE purchase and sale | --0 | ---75.56K | 31.84%-54.53K | ---54.53K | --0 | --0 | --0 | -60.00%-80K | --0 | --0 |
| Net business purchase and sale | ---- | ---- | --6.2K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---75.56K | 39.59%-48.33K | ---48.33K | --0 | --0 | --0 | -60.00%-80K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 258.24%4.28M | 292.21%4.27M | 0 | 108.35%1.19M | 1.09M | 0 | ||||
| Net common stock issuance | ---- | ---- | --4.25M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.09M | ---- | ---- |
| Net other financing activities | ---- | ---- | -73.30%27.9K | --23.4K | --0 | ---- | ---- | --104.5K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | 258.24%4.28M | 292.21%4.27M | --0 | ---- | ---- | 108.35%1.19M | --1.09M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 598,966,000.00%5.99M | 643,203,600.00%6.43M | 25.63%3.06M | 40.06%2.95M | 30.52%2.98M | --1 | --1 | -2.68%2.43M | --2.11M | --2.29M |
| Current changes in cash | ---505.61K | ---442.38K | 441.57%3.38M | 266.54%3.48M | 81.47%-33.23K | ---- | ---- | 1,030.17%623.38K | --950.14K | ---179.36K |
| End cash Position | 83.87%5.48M | 598,966,000.00%5.99M | 110.47%6.43M | 110.47%6.43M | 40.06%2.95M | --2.98M | --1 | 25.63%3.06M | --3.06M | --2.11M |
| Free cash from | -549.21%-505.61K | ---442.38K | -58.84%-905.47K | -472.39%-794.36K | 81.47%-33.23K | ---77.88K | --0 | 10.91%-570.04K | ---138.78K | ---179.36K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.